Patricia Loughlin
About Patricia Loughlin
Patricia Loughlin serves as the National Account Director at Amylyx Pharmaceuticals, where she leverages her extensive experience in market access and account management across various therapeutic areas. With a strong background in managing complex accounts and strategic planning, she has held key positions at several pharmaceutical companies, including Albireo Pharma and Intercept Pharmaceuticals.
Current Role at Amylyx Pharmaceuticals
Patricia Loughlin serves as the National Account Director at Amylyx Pharmaceuticals since 2022. In this role, she focuses on enhancing market access and account management strategies. Her responsibilities include collaborating with various stakeholders to ensure effective coverage and access for the company's pharmaceutical products. Based in Boston, Massachusetts, she continues to leverage her extensive experience in the pharmaceutical industry to drive organizational goals.
Previous Experience at Albireo Pharma, Inc.
Prior to her current position, Loughlin worked at Albireo Pharma, Inc. as the Director of National Accounts from 2021 to 2022. In this capacity, she collaborated with Reimbursement Specialists and Territory Business Managers to improve market access. Her work involved managing specialty pharmacies and implementing compliance and persistency contracts to enhance patient adherence to treatment regimens.
Professional Background in Strategic Accounts
Loughlin has a significant background in managing strategic accounts across various pharmaceutical companies. She held the position of Director of Strategic Accounts at Intercept Pharmaceuticals from 2015 to 2021. Additionally, she served as the National Account Manager at Shionogi Inc. and as Director of Strategic Accounts at Genentech (InterMune). Her roles have involved developing and executing strategic plans for pharmacy and medical benefit products.
Education and Expertise
Loughlin holds a Master of Science in Administration from the University of South Dakota, where she studied Business/Healthcare Administration. She also earned a Bachelor of Arts in Healthcare from the University of Northern Iowa. Her educational background complements her extensive experience in various therapeutic areas, including oncology, HIV/AIDS, and chronic care treatments.
Achievements in Market Access and Account Management
Throughout her career, Loughlin has demonstrated success in achieving excellent coverage and access for products in both rare specialty biotech pharmaceuticals and chronic care treatments. She has worked closely with HUBs to conduct GAP analyses aimed at improving service levels and compliance. Her expertise spans multiple therapeutic areas and includes a strong focus on brand and portfolio payer segment marketing.